Notable is a technology-powered precision medicine company. Using its unique prediction technology platform, Notable is developing a new class of cancer medicines that are focused on the patients who are predicted to clinically respond. In June 2020, our team published early feasibility studies with Stanford University demonstrating 85% accuracy. Our platform thus enables the development of medicines with better patient outcomes, a faster development speed and less risk of failure – a leap for precision medicine. Notable is located in the San Francisco Bay Area.